Psoriatic Arthritis Clinical Research Study

About This Study

This study is investigating an innovative treatment for adults with active psoriatic arthritis who have both joint and skin involvement. The investigational medication targets specific immune pathways involved in both the joint inflammation and skin manifestations of psoriatic arthritis.

What is Psoriatic Arthritis?

Psoriatic arthritis (PsA) is a chronic inflammatory condition that occurs in some people with psoriasis. It causes joint pain, stiffness, and swelling, often alongside the skin plaques and nail changes of psoriasis. PsA can affect any joint, including the spine, and may cause permanent damage if left untreated.

Learn more about PsA at Overlake Arthritis →

Who May Qualify

• Adults 18 years or older
• Diagnosed with psoriatic arthritis
• Active joint symptoms (swollen or tender joints)
• History of or current psoriasis
• Inadequate response to at least one prior treatment

What Participation Involves

• Screening: Physical exam, blood tests, joint assessment, skin evaluation
• Treatment: Approximately 24-48 weeks of study medication
• Visits: Every 4-6 weeks for joint counts and skin assessments
• Follow-up: Safety monitoring after treatment

Compensation

• All study-related care at no cost
• Study medication provided at no charge
• Compensation for your time and travel